LDL-cholesterol signaling induces breast cancer proliferation and invasion

Lipids in Health and Disease

Volumn 13, Issue 1, 2014, Pages

  Rodrigues Dos Santos, Catarina ^a,b,d   Domingues, Germana ^c   Matias, Inês ^c   Matos, João ^b   Fonseca, Isabel ^b,d   De Almeida, José Mendes ^b,d   Dias, Sérgio ^c,d  

^a Gulbenkian Program for Advanced Medical Education   (Portugal)

^b INSTITUTO PORTUGUÊS DE ONCOLOGIA DE LISBOA FRANCISCO GENTIL   (Portugal)

^c Instituto Medicina Molecular   (Portugal)

^d INSTITUTO DE MEDICINA MOLECULAR   (Portugal)

Author keywords

Breast cancer; LDL cholesterol; Tumor growth

Indexed keywords

CADHERIN RELATED FAMILY MEMBER 3; CLAUDIN 7; EPIDERMAL GROWTH FACTOR RECEPTOR 2; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MITOGEN ACTIVATED PROTEIN KINASE; OCCLUDIN; PROTEIN; PROTEIN KINASE B; STRESS ACTIVATED PROTEIN KINASE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST CANCER; CANCER GROWTH; CANCER STAGING; CELL ADHESION; CELL MIGRATION; CELL PROLIFERATION; CELL SURVIVAL; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DOWN REGULATION; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; GENE INTERACTION; HUMAN; HUMAN CELL; HYPERCHOLESTEROLEMIA; IN VITRO STUDY; IN VIVO STUDY; LUNG METASTASIS; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; TUMOR GROWTH; TUMOR INVASION;

ANIMALS; BREAST NEOPLASMS; CELL ADHESION; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CHOLESTEROL, LDL; DIET, HIGH-FAT; FEMALE; GENE EXPRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LUNG NEOPLASMS; MICE; MICE, INBRED BALB C; MICE, SCID; NEOPLASM INVASIVENESS; NEOPLASM TRANSPLANTATION; PROTEIN PROCESSING, POST-TRANSLATIONAL; SIGNAL TRANSDUCTION; TUMOR BURDEN;

EID: 84892688849     PISSN: None     EISSN: 1476511X     Source Type: Journal    
DOI: 10.1186/1476-511X-13-16     Document Type: Article

References (38)

1. Lipid rafts as a membrane-organizing principle. Lingwood D, Simons K, Science 2010 327 5961 46 50 10.1126/science.1174621 20044567
2. Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis. Menendez JA, Lupu R, Nat Rev Cancer 2007 7 10 763 777 10.1038/nrc2222 17882277
3. Monoacylglycerol lipase regulates a fatty acid network that promotes cancer pathogenesis. Nomura DK, Long JZ, Niessen S, Hoover HS, Ng SW, Cravatt BF, Cell 2010 140 1 49 61 10.1016/j.cell.2009.11.027 20079333
4. Migration of MDA-MB-231 breast cancer cells depends on the availability of exogenous lipids and cholesterol esterification. Antalis CJ, Uchida A, Buhman KK, Siddiqui RA, Clin Exp Metastasis 2011 28 8 733 741 10.1007/s10585-011-9405- 9 21744083
5. The cholesterol content of normal and enlarged prostates. Swyer G, Cancer Res 1942 2 372 375
6. Cholesterol accumulation in heterotransplanted renal cell cancer. Clayman RV, Gonzalez R, Elliott AY, Gleason DE, Dempsey ME, J Urol 1983 129 3 621 624 6834564
7. High ACAT1 expression in estrogen receptor negative basal-like breast cancer cells is associated with LDL-induced proliferation. Antalis CJ, Arnold T, Rasool T, Lee B, Buhman KK, Siddiqui RA, Breast Cancer Res Treat 2010 122 3 661 670 10.1007/s10549-009-0594-8 19851860
8. Serum cholesterol levels in relation to the incidence of cancer: the JPHC study cohorts. Iso H, Ikeda A, Inoue M, Sato S, Tsugane S, Int J Cancer 2009 125 11 2679 2686 10.1002/ijc.24668 19544528
9. Serum cholesterol and the incidence of cancer in a large cohort. Hiatt RA, Fireman BH, J Chronic Dis 1986 39 11 861 870 10.1016/0021-9681(86)90034-2 3793838
10. Serum lipids and breast cancer risk: a cohort study of 5,207 Danish women. Hoyer AP, Engholm G, Cancer Causes Control 1992 3 5 403 408 10.1007/BF00051352 1525320
11. Serum lipids, lipid-lowering drugs, and the risk of breast cancer. Eliassen AH, Colditz GA, Rosner B, Willett WC, Hankinson SE, Arch Intern Med 2005 165 19 2264 2271 10.1001/archinte.165.19.2264 16246993
12. Risk of breast cancer in relation to blood lipids: a prospective study of 31,209 Norwegian women. Gaard M, Tretli S, Urdal P, Cancer Causes Control 1994 5 6 501 509 10.1007/BF01831377 7827236
13. Total cholesterol and cancer risk in a large prospective study in Korea. Kitahara CM, Berrington De Gonzalez A, Freedman ND, Huxley R, Mok Y, Jee SH, Samet JM, J Clin Oncol 2011 29 12 1592 1598 10.1200/JCO.2010.31.5200 21422422
14. Statin use, hyperlipidaemia, and the risk of breast cancer. Kaye JA, Meier CR, Walker AM, Jick H, Br J Cancer 2002 86 9 1436 1439 10.1038/sj.bjc.6600267 11986777
15. NIH Image to ImageJ: 25 years of image analysis. Schneider CA, Rasband WS, Eliceiri KW, Nature Methods 2012 9 671 675 http://www.nature.com/nmeth/ journal/v9/n7/full/nmeth.2089.html 10.1038/nmeth.2089 22930834
16. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ, N Engl J Med 2003 348 17 1625 1638 10.1056/NEJMoa021423 12711737
17. Cardiovascular risk in the Asia-Pacific region from a nutrition and metabolic point of view: visceral obesity. Sullivan DR, Asia Pac J Clin Nutr 2001 10 2 82 84 10.1046/j.1440-6047.2001.00229.x 11710362
18. Major causes of death among men and women in China. He J, Gu D, Wu X, Reynolds K, Duan X, Yao C, Wang J, Chen CS, Chen J, Wildman RP, et al. N Engl J Med 2005 353 11 1124 1134 10.1056/NEJMsa050467 16162883
19. The basics of epithelial-mesenchymal transition. Kalluri R, Weinberg RA, J Clin Invest 2009 119 6 1420 1428 10.1172/JCI39104 19487818
20. Effects of low- and high-density lipoproteins on the proliferation of human breast cancer cells in vitro: differences between hormone-dependent and hormone-independent cell lines. Rotheneder M, Kostner GM, Int J Cancer 1989 43 5 875 879 10.1002/ijc.2910430523 2714893
21. High-density lipoproteins and the proliferation of human tumor cells maintained on extracellular matrix-coated dishes and exposed to defined medium. Gospodarowicz D, Lui GM, Gonzalez R, Cancer Res 1982 42 9 3704 3713 7049362
22. A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes. Neve RM, Chin K, Fridlyand J, Yeh J, Baehner FL, Fevr T, Clark L, Bayani N, Coppe JP, Tong F, et al. Cancer Cell 2006 10 6 515 527 10.1016/j.ccr.2006.10.008 17157791
23. Systemic LDL Promotes Breast Cancer Progression. Santos CR, Mendes Almeida JC, Dias S, Ann Surg Oncol 2012 19 2 Supplement 100 101
24. Amplification of a novel v-erbB-related gene in a human mammary carcinoma. King CR, Kraus MH, Aaronson SA, Science 1985 229 4717 974 976 10.1126/science.2992089 2992089
25. Cholesterol levels modulate EGF receptor-mediated signaling by altering receptor function and trafficking. Pike LJ, Casey L, Biochemistry 2002 41 32 10315 10322 10.1021/bi025943i 12162747
26. Cholesterol is important in control of EGF receptor kinase activity but EGF receptors are not concentrated in caveolae. Ringerike T, Blystad FD, Levy FO, Madshus IH, Stang E, J Cell Sci 2002 115 Pt 6 1331 1340 11884532
27. Cholesterol dictates the freedom of EGF receptors and HER2 in the plane of the membrane. Orr G, Hu D, Ozcelik S, Opresko LK, Wiley HS, Colson SD, Biophys J 2005 89 2 1362 1373 10.1529/biophysj.104.056192 15908575
28. Cholesterol depletion from the plasma membrane triggers ligand-independent activation of the epidermal growth factor receptor. Chen X, Resh MD, J Biol Chem 2002 277 51 49631 49637 10.1074/jbc.M208327200 12397069
29. Role of cholesterol in the development and progression of breast cancer. Llaverias G, Danilo C, Mercier I, Daumer K, Capozza F, Williams TM, Sotgia F, Lisanti MP, Frank PG, Am J Pathol 2011 178 1 402 412 10.1016/j.ajpath.2010.11. 005 21224077
30. A Western-type diet accelerates tumor progression in an autochthonous mouse model of prostate cancer. Llaverias G, Danilo C, Wang Y, Witkiewicz AK, Daumer K, Lisanti MP, Frank PG, Am J Pathol 2010 177 6 3180 3191 10.2353/ajpath.2010.100568 21088217
31. Ki-67 as prognostic marker in early breast cancer: a meta-analysis of published studies involving 12,155 patients. De Azambuja E, Cardoso F, De Castro G Jr, Colozza M, Mano MS, Durbecq V, Sotiriou C, Larsimont D, Piccart-Gebhart MJ, Paesmans M, Br J Cancer 2007 96 10 1504 1513 10.1038/sj.bjc.6603756 17453008
32. Lack of predictability of classical animal models for hypolipidemic activity: a good time for mice? Krause BR, Princen HM, Atherosclerosis 1998 140 1 15 24 10.1016/S0021-9150(98)00141-5 9733211
33. Statins and cancer risk: a literature-based meta-analysis and meta-regression analysis of 35 randomized controlled trials. Bonovas S, Filioussi K, Tsavaris N, Sitaras NM, J Clin Oncol 2006 24 30 4808 4817 10.1200/JCO.2006.06.3560 17001070
34. Statins and cancer risk: a meta-analysis. Dale KM, Coleman CI, Henyan NN, Kluger J, White CM, JAMA 2006 295 1 74 80 10.1001/jama.295.1.74 16391219
35. Statin use and reduced cancer-related mortality. Nielsen SF, Nordestgaard BG, Bojesen SE, N Engl J Med 2012 367 19 1792 1802 10.1056/NEJMoa1201735 23134381
36. Correspondence. Statin Use and Reduced Cancer-Related Mortality. Nielsen SF, Nordestgaard BG, Bojesen SE, N Engl J Med 2013 368 574 577 February 7, 2013. DOI: 10.1056/NEJMc1214827
37. Dysregulation of the mevalonate pathway promotes transformation. Clendening JW, Pandyra A, Boutros PC, El Ghamrasni S, Khosravi F, Trentin GA, Martirosyan A, Hakem A, Hakem R, Jurisica I, et al. Proceedings of the National Academy of Sciences of the United States of America 2010 107 34 15051 15056 10.1073/pnas.0910258107 20696928
38. Targeting HMG-CoA reductase with statins in a window-of-opportunity breast cancer trial. Bjarnadottir O, Romero Q, Bendahl PO, Jirstrom K, Ryden L, Loman N, Uhlen M, Johannesson H, Rose C, Grabau D, et al. Breast Cancer Res Treat 2013 138 2 499 508 10.1007/s10549-013-2473-6 23471651